Our AI technology pre-screens and matches your patients to the best clinical trials and streamlining your workflow.
interventional cancer clinical trials
vs manual pre-screening
more matching clinical trials
Massive Bio offers free trial services, granting access to potential life-saving treatments. Join us to explore diverse treatment options and improve your prognosis and quality of life. Refer your patient to take advantage of their cutting-edge services.
Massive Bio has provided health to more than 130,000 cancer patients in 17 countries across three continents. It collaborates with over 80 global partners. In 2022, Massive Bio became part of the Precision Cancer Consortium (PCC), alongside major companies such as AstraZeneca, Bayer, Eli Lilly & Company, GSK, Johnson & Johnson/Janssen, Novartis and Roche.
Through Massive Bio, referred patients can take advantage of concierge services, making it easier for both physicians and patients to navigate the clinical trial enrollment process. Patient relations coordinators engage patients to answer their questions and understand their current condition, and oncology nurses help patients navigate the clinical trial enrolment process.
Allow artificial intelligence to streamline your process, enabling your patients to reach cutting-edge trials, while enhancing your trial oversight and clinical results.
